Reasons for Discontinuation Matter

“An estimated 50% of patients with a prescription for a chronic condition stop taking it within the first year*”

Premature medication discontinuation is costly.

Everyday millions of patients prematurely discontinue their medications. The implications are costly. This challenge is under addressed due to the lack of understanding of why the patient stopped taking the medication in the first place.

Get to know the patient beyond the claim.

In most cases, reasons for discontinuation are hidden in clinical notes and are extremely difficult to obtain. Accessing those reasons and identifying patterns around discontinuation by patient population subtypes and disease severity can provide critical insights and guidance for your brand strategy, messaging, and patient programs.

Solution: Introducing OM1’s RfD Analytics Report

Leveraging the OM1 Real-World Data Cloud, deep clinical datasets, and proprietary artificial intelligence (AI) technology, OM1 extracts RfD from the clinical narratives of prescribing clinicians and transforms them into structured and characterized data – on the drugs and in the conditions you choose.